Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure

Joel L. Berry, Wuqiang Zhu, Yao Liang Tang, Prasanna Krishnamurthy, Ying Ge, John P. Cooke, Yabing Chen, Daniel J. Garry, Huang Tian Yang, Namakkal Soorapan Rajasekaran, Walter J. Koch, Song Li, Keitaro Domae, Gangjian Qin, Ke Cheng, Timothy J. Kamp, Lei Ye, Shijun Hu, Brenda M. Ogle, Jack M. RogersE. Dale Abel, Michael E. Davis, Sumanth D. Prabhu, Ronglih Liao, William T. Pu, Yibin Wang, Peipei Ping, Nenad Bursac, Gordana Vunjak-Novakovic, Joseph C. Wu, Roberto Bolli, Philippe Menasché, Jianyi Zhang

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

On March 1 and 2, 2018, the National Institutes of Health 2018 Progenitor Cell Translational Consortium, Cardiovascular Bioengineering Symposium, was held at the University of Alabama at Birmingham. Convergence of life sciences and engineering to advance the understanding and treatment of heart failure was the theme of the meeting. Over 150 attendees were present, and >40 scientists presented their latest work on engineering human functional myocardium for disease modeling, drug development, and heart failure research. The scientists, engineers, and physicians in the field of cardiovascular sciences met and discussed the most recent advances in their work and proposed future strategies for overcoming the major roadblocks of cardiovascular bioengineering and therapy. Particular emphasis was given for manipulation and using of stem/progenitor cells, biomaterials, and methods to provide molecular, chemical, and mechanical cues to cells to influence their identity and fate in vitro and in vivo. Collectively, these works are profoundly impacting and progressing toward deciphering the mechanisms and developing novel treatments for left ventricular dysfunction of failing hearts. Here, we present some important perspectives that emerged from this meeting.

Original languageEnglish (US)
Pages (from-to)161-169
Number of pages9
JournalCirculation research
Volume124
Issue number1
DOIs
StatePublished - Jan 4 2019

Fingerprint

Biological Science Disciplines
Bioengineering
Stem Cells
Heart Failure
Human Engineering
Drug Design
National Institutes of Health (U.S.)
Left Ventricular Dysfunction
Biocompatible Materials
Treatment Failure
Cues
Myocardium
Physicians
Therapeutics
Research

Keywords

  • bioengineering
  • heart failure
  • myocardium
  • stem cells
  • tissue engineering

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure. / Berry, Joel L.; Zhu, Wuqiang; Tang, Yao Liang; Krishnamurthy, Prasanna; Ge, Ying; Cooke, John P.; Chen, Yabing; Garry, Daniel J.; Yang, Huang Tian; Rajasekaran, Namakkal Soorapan; Koch, Walter J.; Li, Song; Domae, Keitaro; Qin, Gangjian; Cheng, Ke; Kamp, Timothy J.; Ye, Lei; Hu, Shijun; Ogle, Brenda M.; Rogers, Jack M.; Abel, E. Dale; Davis, Michael E.; Prabhu, Sumanth D.; Liao, Ronglih; Pu, William T.; Wang, Yibin; Ping, Peipei; Bursac, Nenad; Vunjak-Novakovic, Gordana; Wu, Joseph C.; Bolli, Roberto; Menasché, Philippe; Zhang, Jianyi.

In: Circulation research, Vol. 124, No. 1, 04.01.2019, p. 161-169.

Research output: Contribution to journalReview article

Berry, JL, Zhu, W, Tang, YL, Krishnamurthy, P, Ge, Y, Cooke, JP, Chen, Y, Garry, DJ, Yang, HT, Rajasekaran, NS, Koch, WJ, Li, S, Domae, K, Qin, G, Cheng, K, Kamp, TJ, Ye, L, Hu, S, Ogle, BM, Rogers, JM, Abel, ED, Davis, ME, Prabhu, SD, Liao, R, Pu, WT, Wang, Y, Ping, P, Bursac, N, Vunjak-Novakovic, G, Wu, JC, Bolli, R, Menasché, P & Zhang, J 2019, 'Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure', Circulation research, vol. 124, no. 1, pp. 161-169. https://doi.org/10.1161/CIRCRESAHA.118.314216
Berry, Joel L. ; Zhu, Wuqiang ; Tang, Yao Liang ; Krishnamurthy, Prasanna ; Ge, Ying ; Cooke, John P. ; Chen, Yabing ; Garry, Daniel J. ; Yang, Huang Tian ; Rajasekaran, Namakkal Soorapan ; Koch, Walter J. ; Li, Song ; Domae, Keitaro ; Qin, Gangjian ; Cheng, Ke ; Kamp, Timothy J. ; Ye, Lei ; Hu, Shijun ; Ogle, Brenda M. ; Rogers, Jack M. ; Abel, E. Dale ; Davis, Michael E. ; Prabhu, Sumanth D. ; Liao, Ronglih ; Pu, William T. ; Wang, Yibin ; Ping, Peipei ; Bursac, Nenad ; Vunjak-Novakovic, Gordana ; Wu, Joseph C. ; Bolli, Roberto ; Menasché, Philippe ; Zhang, Jianyi. / Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure. In: Circulation research. 2019 ; Vol. 124, No. 1. pp. 161-169.
@article{99e1db3bdd214de39bf59e7e3c8c52ca,
title = "Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure",
abstract = "On March 1 and 2, 2018, the National Institutes of Health 2018 Progenitor Cell Translational Consortium, Cardiovascular Bioengineering Symposium, was held at the University of Alabama at Birmingham. Convergence of life sciences and engineering to advance the understanding and treatment of heart failure was the theme of the meeting. Over 150 attendees were present, and >40 scientists presented their latest work on engineering human functional myocardium for disease modeling, drug development, and heart failure research. The scientists, engineers, and physicians in the field of cardiovascular sciences met and discussed the most recent advances in their work and proposed future strategies for overcoming the major roadblocks of cardiovascular bioengineering and therapy. Particular emphasis was given for manipulation and using of stem/progenitor cells, biomaterials, and methods to provide molecular, chemical, and mechanical cues to cells to influence their identity and fate in vitro and in vivo. Collectively, these works are profoundly impacting and progressing toward deciphering the mechanisms and developing novel treatments for left ventricular dysfunction of failing hearts. Here, we present some important perspectives that emerged from this meeting.",
keywords = "bioengineering, heart failure, myocardium, stem cells, tissue engineering",
author = "Berry, {Joel L.} and Wuqiang Zhu and Tang, {Yao Liang} and Prasanna Krishnamurthy and Ying Ge and Cooke, {John P.} and Yabing Chen and Garry, {Daniel J.} and Yang, {Huang Tian} and Rajasekaran, {Namakkal Soorapan} and Koch, {Walter J.} and Song Li and Keitaro Domae and Gangjian Qin and Ke Cheng and Kamp, {Timothy J.} and Lei Ye and Shijun Hu and Ogle, {Brenda M.} and Rogers, {Jack M.} and Abel, {E. Dale} and Davis, {Michael E.} and Prabhu, {Sumanth D.} and Ronglih Liao and Pu, {William T.} and Yibin Wang and Peipei Ping and Nenad Bursac and Gordana Vunjak-Novakovic and Wu, {Joseph C.} and Roberto Bolli and Philippe Menasch{\'e} and Jianyi Zhang",
year = "2019",
month = "1",
day = "4",
doi = "10.1161/CIRCRESAHA.118.314216",
language = "English (US)",
volume = "124",
pages = "161--169",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure

AU - Berry, Joel L.

AU - Zhu, Wuqiang

AU - Tang, Yao Liang

AU - Krishnamurthy, Prasanna

AU - Ge, Ying

AU - Cooke, John P.

AU - Chen, Yabing

AU - Garry, Daniel J.

AU - Yang, Huang Tian

AU - Rajasekaran, Namakkal Soorapan

AU - Koch, Walter J.

AU - Li, Song

AU - Domae, Keitaro

AU - Qin, Gangjian

AU - Cheng, Ke

AU - Kamp, Timothy J.

AU - Ye, Lei

AU - Hu, Shijun

AU - Ogle, Brenda M.

AU - Rogers, Jack M.

AU - Abel, E. Dale

AU - Davis, Michael E.

AU - Prabhu, Sumanth D.

AU - Liao, Ronglih

AU - Pu, William T.

AU - Wang, Yibin

AU - Ping, Peipei

AU - Bursac, Nenad

AU - Vunjak-Novakovic, Gordana

AU - Wu, Joseph C.

AU - Bolli, Roberto

AU - Menasché, Philippe

AU - Zhang, Jianyi

PY - 2019/1/4

Y1 - 2019/1/4

N2 - On March 1 and 2, 2018, the National Institutes of Health 2018 Progenitor Cell Translational Consortium, Cardiovascular Bioengineering Symposium, was held at the University of Alabama at Birmingham. Convergence of life sciences and engineering to advance the understanding and treatment of heart failure was the theme of the meeting. Over 150 attendees were present, and >40 scientists presented their latest work on engineering human functional myocardium for disease modeling, drug development, and heart failure research. The scientists, engineers, and physicians in the field of cardiovascular sciences met and discussed the most recent advances in their work and proposed future strategies for overcoming the major roadblocks of cardiovascular bioengineering and therapy. Particular emphasis was given for manipulation and using of stem/progenitor cells, biomaterials, and methods to provide molecular, chemical, and mechanical cues to cells to influence their identity and fate in vitro and in vivo. Collectively, these works are profoundly impacting and progressing toward deciphering the mechanisms and developing novel treatments for left ventricular dysfunction of failing hearts. Here, we present some important perspectives that emerged from this meeting.

AB - On March 1 and 2, 2018, the National Institutes of Health 2018 Progenitor Cell Translational Consortium, Cardiovascular Bioengineering Symposium, was held at the University of Alabama at Birmingham. Convergence of life sciences and engineering to advance the understanding and treatment of heart failure was the theme of the meeting. Over 150 attendees were present, and >40 scientists presented their latest work on engineering human functional myocardium for disease modeling, drug development, and heart failure research. The scientists, engineers, and physicians in the field of cardiovascular sciences met and discussed the most recent advances in their work and proposed future strategies for overcoming the major roadblocks of cardiovascular bioengineering and therapy. Particular emphasis was given for manipulation and using of stem/progenitor cells, biomaterials, and methods to provide molecular, chemical, and mechanical cues to cells to influence their identity and fate in vitro and in vivo. Collectively, these works are profoundly impacting and progressing toward deciphering the mechanisms and developing novel treatments for left ventricular dysfunction of failing hearts. Here, we present some important perspectives that emerged from this meeting.

KW - bioengineering

KW - heart failure

KW - myocardium

KW - stem cells

KW - tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=85059495380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059495380&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.118.314216

DO - 10.1161/CIRCRESAHA.118.314216

M3 - Review article

C2 - 30605412

AN - SCOPUS:85059495380

VL - 124

SP - 161

EP - 169

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 1

ER -